ANTI-EPHA4-ANTIKÖRPER

European patent · EP3995582 · In force

Register entry

Publication number
EP3995582
Application number
EP20834769
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 29, 2020
Published
May 11, 2022
Granted
Apr 22, 2026
Protection ends at the latest
Jun 28, 2040
Next annual fee due
Jun 30, 2027
IPC classes
C12N 15/13 (2006.01)
A61K 39/395 (2006.01)
A61P 25/28 (2006.01)
C07K 16/28 (2006.01)
C12N 1/15 (2006.01)
C12N 1/19 (2006.01)
C12N 1/21 (2006.01)
C12N 5/10 (2006.01)
C12N 15/63 (2006.01)
C12P 21/08 (2006.01)
Priority
JP 2019122982 01.07.2019
PCT application
PCT/JP2020/025465 29.06.2020
PCT publication
WO2021/002312 07.01.2021
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Apr 22, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 22.04.2026

Parties

Holder

Eisai R&D Management Co., Ltd.

4-6-10 Koishikawa Bunkyo-ku, Tokyo 112-8088, JP

Inventor

INOUE, Eiji

Kobe-shi, Hyogo 650-0047, JP

YAMADA, Akio

Kobe-shi, Hyogo 650-0047, JP

KAWAKATSU, Tomomi

Kobe-shi, Hyogo 650-0047, JP

IMAI, Toshio

Kobe-shi, Hyogo 650-0047, JP

DEGUCHI, Maki

Kobe-shi, Hyogo 650-0047, JP

NAKATANI, Aki

Kobe-shi, Hyogo 650-0047, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.